Part II in a series of articles about emerging trends shaping the future of health and wellness, the second installment provides an overview of how financial wellness programs that incorporate life and disability coverage are expanding beyond the group space and moving ... Read More

No study of mortality is complete without a deeper analysis of underlying causes, including seasonal factors. Victor Barriga, Chief Actuary of RGA Spain and Portugal, provides a Read More

RGA Hong Kong and the RGA Asia Pacific regional team explore recent innovations in genetic testing and provide guidance on how insurers can prepare for and adapt to changes on the horizon in the genetic moratorium era.

 

Read More

Actuarial science, and insurance more generally, is a crucible for this concern.  At a 2017 Insurtech Connect Conference in Las Vegas, Chief Executive Officer Daniel Schreiber of the startup Lemonade suggested that AI will supplant the traditional actuarial role...

Read More

Curious about RGA's research?   Contact us to learn more. 

This video was developed in conjunction with actuv...

Read More

Telehealth is growing and likely here to stay beyond the COVID-19 pandemic. While insurers may choose not to directly run their own telehealth programs right now, they should familiarize themselves with program requirements in order to keep up with the rapid development... Read More

RGA Group Reinsurance conducted a survey of Canadian insurers on group optional products to assess the growth in premium in the past five years.
Read More

RGA's Dr. Radi Counsell discusses what can be learned from the two largest clinical trials, RECOVERY in the U.K. and the global SOLIDARITY trials. The concerted research efforts evaluate potential COVID-19 treatments by studying more than 150 different drugs, and  ... Read More

The AI renaissance in insurance has arrived. Winners will be those companies that proactively develop a plan and work to execute it. In other words, go on offense. If you only play defense, the best possible outcome is to simply tie the game. Read More

COVID-19 has unleashed a storm of business, social, and economic change that insurers must navigate. Jonathan Hughes of RGAX offers practical and proven principles and tools to help companies to innovate, adapt, and thrive, not only in the present tumultuous times ... Read More

Part III in a series of articles on developing underwriting thought processes, this third installment focuses on ways to develop critical thinking skills.

Read More

Curious about RGA's research? Contact us to learn more. 

This video was developed in conjunction with actuview, th...

Read More

Curious about RGA's research?   Contact us to learn more. 

This video was developed in conjunction with a...

Read More

What does SARS-CoV-2 reinfection mean in terms of future immunity and vaccine efficacy? RGA's Dr. Georgiana Willwerth-Pascutiu reviews available evidence and warns insurers that confirmed reinfections increase the likelihood that underwriters will encounter this medical... Read More

By 2030, one in every eight of the earth’s inhabitants will be over age 65,[1] and attempts to address the current coronavirus pandemic are shining a particularly punishing light on a silent epidemic of social isola...

Read More

While the long-term health impact of climate change remains unknown, how can the insurance industry prepare its product development processes now to be ready for the changes to come? Read More

The COVID-19 pandemic not only increased reliance on digital platforms, but also accelerated the use of digital payments. While the elderly are often reluctant to adopt new technologies, they may have the most to benefit from a cashless society. As elderly populations b... Read More

Part I in a series of articles about emerging trends shaping the future of health and wellness, the first installment dives deep into the latest advances in wearable technology. RGA's Matt Berkley provides an overview of opportunities the refocused attention on personal... Read More

A safe and effective vaccine against the pathogen behind the novel coronavirus pandemic is eagerly awaited by billions across the globe, hoping to help bring the crisis to an end. RGA's Dr. Summer Zhu provides an update on clinical SARS-CoV-2 vaccine development, with a... Read More

When does a disease stop spreading through a population? The formula is simple: A critical mass of immune individuals can break a chain of infection. The difficulty is in the details and the variables. In ReFlections, RGA's Dr. Karneen Tam explains the tricky m... Read More